CareFusion Awards Best Hospitals - Analyst Blog
Medical technology company
) recently revealed that it recognized 1,187 U.S.-based hospitals
for winning a minimum of one out of four awards conferred to the
country's top-notch medical institutions. The company stated that
the awards recognize hospitals who are ahead of their cohort in
parameters such as quality of care, nursing, financial reporting
and information technology.
As part of the process, CareFusion evaluated the winners of four autonomous industry-wide felicitations. These winners exemplify various facets of quality and delivery of health care at hospitals.
CareFusion noted awards handed out to hospitals by four organizations, namely American Nurses Credentialing Center, Hospitals & Health Networks, Thompson Reuters and U.S. News & World Report.
Every year, CareFusion utilizes the awards handed out by the four above-mentioned entities to come up with its own 'Best of the Best' selection of America's hospitals.
In the end, just half a dozen hospitals received all four awards. CareFusion noted that it is a supplier to five out of six winning hospitals. The six medical institutions are Hackensack Regional Medical Center in Hackensack, New Jersey, Christ Hospital & Medical Center in Oak Lawn and Carle Foundation Hospital in Urbana, Illinois, University of California San Diego Medical Center - Hillcrest in San Diego, Baystate Medical Center in Springfield, Massachusetts and Banner Good Samaritan Medical Center in Phoenix.
CareFusion is a medical technology company with a global foot print. It competes with Baxter International Inc. ( BAX ), Becton, Dickinson and Company ( BDX ) and Omnicell Inc. ( OMCL ) in certain niches. CareFusion currently retains a Zacks #1 Rank, which translates into a short-term Strong Buy rating.
BAXTER INTL (BAX): Free Stock Analysis Report
BECTON DICKINSO (BDX): Free Stock Analysis Report
CAREFUSION CORP (CFN): Free Stock Analysis Report
OMNICELL INC (OMCL): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research